Fertility

This is the part of the gene therapy pathway that has to be dealt with first, because the window to do anything about it closes before treatment starts.

It does not belong to one stage of the journey. It sits across the whole thing, and it is the reason the order of events matters so much.

What the risk actually is

The chemotherapy given before the cells go back in, the conditioning, can stop you being able to have children. The regulator's wording is that "infertility has been observed with myeloablative conditioning". The patient leaflet puts it more directly: it may not be possible for you to become pregnant or father a child afterwards.

It is the chemotherapy that does this, not the gene editing. There are no data at all on what the gene therapy itself does to fertility, it has not been studied in people or in animals.

What the published follow-up shows

One study has followed fertility outcomes in people who had gene therapy for these conditions. It is worth reading carefully, because it says more than the labels do.

Of 40 patients at a single centre, 17 women were followed for more than a year afterwards. All 17 had signs of ovarian failure. Not some. All of them.

This is one centre, 40 people, and the ovarian failure finding rests on 17 women. It is the best evidence that exists rather than a settled figure for everyone. But it is a long way from "fertility may be affected", and anyone deciding about this treatment deserves the stronger version.

For men the picture was less uniform: two men in the study fathered children afterwards without using the sperm they had banked. But the same study found something else worth knowing, men with sickle cell disease were banking less sperm, at lower concentrations, before treatment even started. Fertility can already be reduced by the condition itself, which is an argument for starting the conversation early and expecting it may take more than one attempt.

What can be preserved, and when

NICE guidance says fertility preservation should be discussed with anyone about to have treatment likely to damage their fertility. For this pathway, that conversation should happen at the first realistic opportunity.

• Sperm freezing is offered to men and boys of reproductive age. It is well established, and treatment using frozen sperm works as well as using fresh.

• Egg or embryo freezing is offered to women and girls of reproductive age.

• Ovarian tissue freezing is considered where egg or embryo freezing is not possible, for example in girls before puberty.

• Testicular tissue freezing, the equivalent option for boys before puberty, is described by NICE as still experimental.

Why the timing is so tight

Conditioning chemotherapy is given in the few days before the infusion, and it is the conditioning that causes the damage. So preservation has to be finished before conditioning begins, and in practice before the earlier stages too, because a negative pregnancy test is required before each round of stem cell mobilisation.

An egg collection cycle alone usually takes two to three weeks, and in the study above women often needed more than one cycle. Add counselling, consent and screening on top. That is why this cannot be left until the treatment date is booked.

Who pays for it

Fertility preservation before treatment that damages fertility is normally NHS funded. NICE is explicit that the eligibility rules used for ordinary fertility treatment, including the lower age limit, should not be applied to preservation in this situation.

Two things to check locally, because they genuinely vary:

• How long storage is funded for. NICE recommends reviewing at least every five years, but local health boards have had quite different policies, some funding three years, others ten, others to a set age.

• The rules that apply later, when you want to use what was stored. NICE notes that ordinary assisted-conception eligibility criteria do apply at that point, which is not the same as the rules for storing it.

Funded storage and legal storage are different things. The law allows eggs, sperm and embryos to be stored for up to 55 years, provided you renew your consent every 10 years. That is the legal maximum, not a promise about who pays.

Pregnancy and contraception around treatment

• A negative pregnancy test is required before each round of mobilisation, and again before conditioning.

• Gene therapy must not be given during pregnancy, because of the conditioning chemotherapy.

• Effective contraception is required from the start of mobilisation until at least six months after the infusion, note that the clock starts at mobilisation, not at the infusion.

• Breast-feeding must stop during conditioning.

Questions you might take to your team

• What are my preservation options, and which would you recommend exploring first?

• Who refers me, and how quickly can that happen?

• How long would preservation add to the timeline before treatment?

• Is it funded here, and for how long is storage funded?

• What is known about my own fertility now, before any treatment?

• If I am not sure whether I want children, what keeps the most options open?